Netherlands: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Netherlands

The Dutch prophylactic medicaments containing insulin market was finally on the rise to reach $X in 2022, after two years of decline. Over the period under review, consumption enjoyed resilient growth. Over the period under review, the market hit record highs at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Netherlands

In value terms, prophylactic medicaments containing insulin production fell to $X in 2022 estimated in export price. In general, production showed a buoyant expansion. The most prominent rate of growth was recorded in 2013 when the production volume increased by 59% against the previous year. Prophylactic medicaments containing insulin production peaked at $X in 2019; afterwards, it flattened through to 2022.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from the Netherlands

For the fourth consecutive year, the Netherlands recorded growth in shipments abroad of medicaments containing insulin but not antibiotics in measured doses, which increased by 17% to X tons in 2022. Over the period under review, exports enjoyed a resilient expansion. The most prominent rate of growth was recorded in 2021 with an increase of 279% against the previous year. Over the period under review, the exports attained the maximum at X tons in 2013; however, from 2014 to 2022, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2022. Overall, exports recorded significant growth. The most prominent rate of growth was recorded in 2021 when exports increased by 521% against the previous year. The exports peaked in 2022 and are likely to see steady growth in the near future.

Exports by Country

The UK (X tons) was the main destination for prophylactic medicaments containing insulin exports from the Netherlands, accounting for a 46% share of total exports. Moreover, prophylactic medicaments containing insulin exports to the UK exceeded the volume sent to the second major destination, Denmark (X tons), fivefold. The third position in this ranking was taken by Spain (X tons), with a 7.2% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to the UK totaled +99.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Denmark (+17.1% per year) and Spain (+53.7% per year).

In value terms, the UK ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from the Netherlands, comprising 53% of total exports. The second position in the ranking was held by Denmark ($X), with a 7.6% share of total exports. It was followed by Germany, with a 6.6% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the UK amounted to +108.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Denmark (+33.3% per year) and Germany (+38.8% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, surging by 2.9% against the previous year. Over the period under review, the export price posted buoyant growth. The most prominent rate of growth was recorded in 2021 when the average export price increased by 64%. The export price peaked in 2022 and is expected to retain growth in the near future.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while the average price for exports to the United Arab Emirates ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (+13.8%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into the Netherlands

In 2022, imports of medicaments containing insulin but not antibiotics in measured doses into the Netherlands skyrocketed to X tons, growing by 24% on 2021 figures. The total import volume increased at an average annual rate of +1.9% over the period from 2012 to 2022; the trend pattern remained relatively stable, with only minor fluctuations being recorded throughout the analyzed period. Over the period under review, imports attained the maximum at X tons in 2014; however, from 2015 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports shrank slightly to $X in 2022. Overall, imports saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2015 with an increase of 20%. Imports peaked at $X in 2018; however, from 2019 to 2022, imports failed to regain momentum.

Imports by Country

Denmark (X tons), Belgium (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to the Netherlands, with a combined 90% share of total imports. India and Germany lagged somewhat behind, together accounting for a further 7.8%.

From 2012 to 2022, the biggest increases were recorded for India (with a CAGR of +76.4%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to the Netherlands, comprising 51% of total imports. The second position in the ranking was held by Belgium ($X), with a 24% share of total imports. It was followed by France, with a 16% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Denmark stood at +3.4%. The remaining supplying countries recorded the following average annual rates of imports growth: Belgium (+48.5% per year) and France (-10.1% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, reducing by -19.8% against the previous year. In general, the import price recorded a slight reduction. The most prominent rate of growth was recorded in 2015 an increase of 38% against the previous year. The import price peaked at $X per ton in 2016; however, from 2017 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Belgium ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+2.1%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :